What is the appropriate dosage of co‑amoxiclav (amoxicillin/clavulanic acid) for a 9‑month‑old infant?

Co-amoxiclav Dosing for 9-Month-Old Infants

For a 9-month-old infant, co-amoxiclav should be dosed at 45 mg/kg/day of the amoxicillin component divided into two daily doses (22.5 mg/kg twice daily), or alternatively 90 mg/kg/day in two doses for more severe infections or suspected resistant organisms.

Standard Dosing Recommendations

The FDA-approved dosing for co-amoxiclav in infants ≥3 months is based on the amoxicillin component 1:

• Standard dose: 45 mg/kg/day divided into 2 doses (using the 4:1 ratio formulation)
• High dose: 90 mg/kg/day divided into 2 doses (for resistant pathogens or severe infections)

Specific Clinical Context

For common pediatric infections in a 9-month-old:

• Acute otitis media (standard): 45 mg/kg/day in 2 divided doses 2, 3
• Acute otitis media (recurrent/persistent): 90 mg/kg/day in 2 divided doses 3, 2
• Haemophilus influenzae infections (if β-lactamase producing): 45-90 mg/kg/day in 2-3 divided doses 2, 3

Practical Administration

Key points for caregivers 1:

• Administer with meals or snacks to reduce gastrointestinal upset
• Use a dosing spoon or medicine dropper for accurate measurement
• Refrigerate suspension and shake well before each use
• Complete the full course even if symptoms improve

Formulation Considerations

The 600 mg/42.9 mg per 5 mL suspension (14:1 ratio) is specifically designed for twice-daily dosing and provides adequate coverage while minimizing clavulanic acid exposure, which reduces gastrointestinal side effects 1. This formulation achieves mean peak amoxicillin concentrations of 15.7 mcg/mL in pediatric patients 1.

Important Caveats

• Safety not established for infants <3 months of age 1
• The high-dose formulation (90 mg/kg/day) should be reserved for suspected resistant Streptococcus pneumoniae or treatment failures 3
• Monitor for diarrhea; if severe or bloody, contact physician immediately as this may indicate Clostridioides difficile infection 1
• Each 5 mL of the 600/42.9 formulation contains 7 mg phenylalanine (relevant for phenylketonurics) 1

When to Use Co-amoxiclav vs Amoxicillin Alone

Use co-amoxiclav specifically when:

• β-lactamase-producing organisms suspected (H. influenzae, M. catarrhalis) 2, 3
• Treatment failure after amoxicillin alone 4
• Recurrent acute otitis media 5

Use amoxicillin alone for:

• Streptococcus pneumoniae infections (non-β-lactamase producer) 2
• Group A Streptococcus 2, 3

The addition of clavulanic acid increases gastrointestinal side effects and should only be used when β-lactamase-producing organisms are suspected or documented 6.